LINDSTROM RICHARD L MD — SEC Form 4 filings
SEC reporting owner CIK 1242177. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-09 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 70,229 shares, $530,954 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 60,229 shares @ $7.66 ($461,354) in OCULAR THERAPEUTIX, INC, filed 2026-02-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | Director | 5 | 2 legs · 70,229 sh · $530,954 | — | 10 |
| LENSAR, Inc. (LNSR) | Director | 3 | — | — | 3 |
Form 4 filings — LINDSTROM RICHARD L MD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/award (A): 14,000 @ $0 · Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 17,421 @ $0 | EDGAR |
| 2026-02-24 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Purchase (P): 60,229 @ $7.66 | EDGAR |
| 2025-06-13 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/award (A): 14,000 @ $0 · Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2025-05-28 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 7,374 @ $0 | EDGAR |
| 2025-05-12 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Purchase (P): 10,000 @ $6.96 | EDGAR |
| 2024-07-26 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Option exercise (M): 18,939 @ $8.80 · Option exercise (M): 11,363 @ $8.80 · Grant/award (A): 12,000 @ $0 · Option exercise (M): 18,939 (derivative) @ $0 · Option exercise (M): 11,363 (derivative) @ $0 · Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2024-05-09 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 22,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1242177 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →